相关实验视频
Updated: Feb 27, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
克服冠状动脉支架中的克洛皮多格勒抗性:用提卡格勒和提克洛匹丁的经验
Pavol Vigláš1,2, Jan Raupach2,3, Aleš Hejčl4
1Department of Radiology, J. E. Purkyně University-Faculty of Health Studies and Krajská zdravotní-Masaryk Hospital, Sociální péče 3316/12A, 401 13 Ústí nad Labem, Czech Republic.
Clinics and practice
|February 26, 2026
概括
治疗中高血小板对克洛皮多格雷尔的反应性在 carotid stenting 后很常见. 提卡格勒勒有效地降低了这些患者的血小板反应性,这表明定制的抗血小板治疗是有益的.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 干预神经病学 干预神经病学
背景情况:
- 冠状动脉支架需要有效的抗血小板治疗.
- 对克洛皮多格雷尔的高治疗时血小板反应率 (HTPR) 可能会损害治疗的疗效.
- 识别HTPR对于预防血栓栓塞事件至关重要.
研究的目的:
- 确定阿司匹林和克洛皮多格雷尔对HTPR的发生率,在接受动脉支架的患者中.
- 评估Ticagrelor和Ticlopidine在HTPR患者中对Clopidogrel的疗效.
主要方法:
- 对216名连续接受动脉支架治疗的患者进行了回顾性分析.
- 使用光传导聚合度和Multiplate®进行血小板功能测试.
- 对阿司匹林,克洛皮多格雷尔,提克洛皮丁和提卡格雷勒的HTPR的评估.
主要成果:
- 在31.4% (68/216) 的患者中观察到HTPR对克洛皮多格雷尔.
- 没有观察到HTPR与ticagrelor或ticlopidine.
- 提卡格勒罗和提克洛皮丁显著降低了HTPR患者对克洛皮多格雷尔的血小板反应性.
结论:
- 对克洛皮多格雷尔的HTPR在接受大脑动脉支架的患者中很普遍.
- 蒂卡格勒勒是克洛皮多格雷尔诱导的HTPR患者的有效替代品.
- 血小板功能测试可以指导定制的抗血小板策略,以减少并发症.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Peripheral Artery Disease III: Interprofessional Care
433
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Coronary Artery Disease V: Interprofessional Care
343
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Acute Coronary Syndrome IV: Interprofessional Care
337
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
337
Angina IV: Management
359
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
359
Venous Thrombosis III: Interprofessional Care
410
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410

